Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal rod cell | 5 studies | 33% ± 9% | |
| microglial cell | 5 studies | 22% ± 7% | |
| endothelial cell | 4 studies | 17% ± 2% | |
| GABAergic neuron | 3 studies | 30% ± 2% | |
| glutamatergic neuron | 3 studies | 39% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1430.54 | 1445 / 1445 | 100% | 23.40 | 183 / 183 |
| brain | 100% | 1412.00 | 2642 / 2642 | 100% | 26.78 | 704 / 705 |
| intestine | 100% | 1904.73 | 966 / 966 | 100% | 23.68 | 526 / 527 |
| stomach | 100% | 985.51 | 359 / 359 | 99% | 21.91 | 284 / 286 |
| breast | 100% | 1252.74 | 459 / 459 | 99% | 23.99 | 1109 / 1118 |
| lung | 100% | 1550.89 | 578 / 578 | 99% | 18.36 | 1145 / 1155 |
| thymus | 100% | 1207.64 | 653 / 653 | 99% | 17.21 | 598 / 605 |
| uterus | 100% | 1379.07 | 170 / 170 | 98% | 19.60 | 452 / 459 |
| bladder | 100% | 1431.29 | 21 / 21 | 98% | 18.51 | 496 / 504 |
| kidney | 100% | 975.31 | 89 / 89 | 98% | 18.24 | 883 / 901 |
| skin | 100% | 906.14 | 1805 / 1809 | 98% | 39.62 | 463 / 472 |
| pancreas | 99% | 632.36 | 324 / 328 | 99% | 19.80 | 176 / 178 |
| prostate | 100% | 1088.98 | 245 / 245 | 97% | 12.49 | 489 / 502 |
| adrenal gland | 100% | 1003.56 | 257 / 258 | 96% | 21.76 | 220 / 230 |
| ovary | 100% | 1071.34 | 180 / 180 | 94% | 13.48 | 403 / 430 |
| liver | 98% | 540.81 | 221 / 226 | 92% | 10.39 | 374 / 406 |
| adipose | 100% | 1370.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1728.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 22.37 | 29 / 29 |
| spleen | 100% | 1384.64 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 23.08 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.69 | 1 / 1 |
| heart | 97% | 678.76 | 837 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 519.57 | 771 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 1326.38 | 883 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 34.35 | 76 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002089 | Biological process | lens morphogenesis in camera-type eye |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0030719 | Biological process | P granule organization |
| GO_0070306 | Biological process | lens fiber cell differentiation |
| GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
| GO_0034587 | Biological process | piRNA processing |
| GO_0033391 | Cellular component | chromatoid body |
| GO_0035770 | Cellular component | ribonucleoprotein granule |
| GO_0043186 | Cellular component | P granule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0003729 | Molecular function | mRNA binding |
| Gene name | TDRD7 |
| Protein name | Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap) |
| Synonyms | PCTAIRE2BP |
| Description | FUNCTION: Component of specific cytoplasmic RNA granules involved in post-transcriptional regulation of specific genes: probably acts by binding to specific mRNAs and regulating their translation. Required for lens transparency during lens development, by regulating translation of genes such as CRYBB3 and HSPB1 in the developing lens. Also required during spermatogenesis. . |
| Accessions | Q8NHU6 ENST00000355295.5 [Q8NHU6-1] |
